Glaxosmithkline Pharmaceuticals balance sheet

As of Mar 2026

Total assets: ₹4,324cr+5.3% on Mar 2025
Shareholders' equity: ₹2,285cr+17.1% on Mar 2025
Total debt: ₹0.0crNo figure a year before
Cash and investments: ₹2,493cr+50.4% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	274	270	297	295
	32.9	14.3	13.9	20.3
	0.7	0.8	0.9	1.1
	6.6	13.3	23.6	34.1
	0.9	0.0	0.0	0.0
	0.0	0.0	0.0	70.0
	13.4	11.5	10.2	12.1
	13.4	11.5	10.2	82.1
	134	141	146	134
	77.3	51.9	52.8	52.4
	539	502	545	618
	458	482	525	460
	1,391	1,118	813	518
	273	293	222	192
	1,102	539	64.2	34.9
	289	865	999	1,121
	39.2	70.8	130	138
	3,094	2,885	2,229	2,004
	54.4	43.1	44.7	30.0
	3,785	3,606	3,012	2,708
	4,324	4,108	3,557	3,327
Equity
	169	169	169	169
	2,098	1,782	1,608	1,572
	2,267	1,951	1,778	1,741
	17.3	0.0	0.0	0.0
	2,285	1,951	1,778	1,741
Liabilities
	—	2.5	6.6	4.1
	0.0	2.5	6.6	4.1
	260	249	247	255
	260	252	254	259
	570	708	625	428
	126	184	154	128
	696	893	780	556
	419	416	394	418
	546	525	299	296
	118	71.5	53.1	56.2
	1,779	1,905	1,525	1,326
	2,039	2,157	1,779	1,585
	4,324	4,108	3,557	3,327
Assets — additional as-filed lines
	179	196	214	214
Trade payables — MSME split
	6.7	8.5	—	—
	564	700	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GLAXO₹2,498.00

Glaxosmithkline Pharmaceuticals Ltd.

· Pharma & Health

₹ CrorePeersPFIZER ABBOTINDIA MEDANTA ANTHEM AJANTPHARM IPCALAB GLENMARK BIOCONMcap ₹42,319 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	294.8	296.8	269.5	273.5	273.5
+ Capital Work-in-Progress	20.3	13.9	14.3	32.9	32.9
+ Investment Property	1.1	0.9	0.8	0.7	0.7
+ Other Intangibles	34.1	23.6	13.3	6.6	6.6
+ Investments (Equity Method)	0.0	0.0	0.0	0.9	0.9
+ Long-term Loans	70.0	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	12.1	10.2	11.5	13.4	13.4
Non-current Financial Assets	82.1	10.2	11.5	13.4	13.4
+ Deferred Tax Assets	133.6	146.3	140.9	133.9	133.9
+ Other Non-current Assets	52.4	52.8	51.9	77.3	77.3
Total Non-current Assets	618.4	544.6	502.2	539.2	539.2
Current Assets
+ Inventories	460.0	525.1	481.7	457.6	457.6
+ Current Investments	518.3	813.2	1,118.3	1,391.0	1,391.0
+ Trade Receivables	192.4	222.1	292.6	273.1	273.1
+ Cash & Cash Equivalents	34.9	64.2	538.9	1,102.1	1,102.1
+ Other Bank Balances	1,121.0	999.1	864.7	289.0	289.0
+ Other Current Financial Assets	137.7	130.1	70.8	39.2	39.2
Current Financial Assets	2,004.3	2,228.6	2,885.1	3,094.3	3,094.3
+ Other Current Assets	30.0	44.7	43.1	54.4	54.4
Total Current Assets	2,708.2	3,012.1	3,605.9	3,784.7	3,784.7
Total Assets	3,326.6	3,556.6	4,108.1	4,323.9	4,323.9
Equity
+ Equity Share Capital	169.4	169.4	169.4	169.4	169.4
+ Other Equity / Reserves	1,571.9	1,608.2	1,781.9	2,098.0	2,098.0
Equity — Owners of Parent	1,741.3	1,777.6	1,951.3	2,267.4	2,267.4
+ Minority Interest	0.0	0.0	0.0	17.3	17.3
Total Equity	1,741.3	1,777.6	1,951.3	2,284.7	2,284.7
Liabilities
+ Other Non-current Financial Liab	4.1	6.6	2.5	—	—
Non-current Financial Liabilities	4.1	6.6	2.5	0.0	0.0
+ Provisions — Non-current	254.8	247.5	249.1	260.1	260.1
Non-current Liabilities	258.9	254.0	251.6	260.1	260.1
+ Trade Payables	427.8	625.4	708.3	570.2	570.2
+ Other Current Financial Liab	128.4	154.3	184.5	125.6	125.6
Current Financial Liabilities	556.2	779.7	892.7	695.8	695.8
+ Provisions — Current	417.8	393.5	416.4	419.2	419.2
+ Current Tax Liabilities	296.2	298.6	524.5	546.0	546.0
+ Other Current Liabilities	56.2	53.1	71.5	118.2	118.2
Current Liabilities	1,326.4	1,525.0	1,905.2	1,779.1	1,779.1
Total Liabilities	1,585.3	1,779.0	2,156.8	2,039.2	2,039.2
Total Equity & Liabilities	3,326.6	3,556.6	4,108.1	4,323.9	4,323.9
Assets — additional as-filed lines
+ Current Tax Assets	214.0	213.6	196.0	178.5	178.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	8.5	6.7	6.7
+ Dues to Other Creditors — Current	—	—	699.7	563.5	563.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.